Pliant Therapeutics announced that the latest data from the Phase 1 clinical trial of its investigational drug Pln-101095 for patients with immune checkpoint inhibitor (ICI)-refractory solid tumors will be presented in a special report at the 2026 American Association for Cancer Research (AACR) Annual Meeting.
Pliant Therapeutics announced that the latest data from the Phase 1 clinical trial of its investigational drug Pln-101095 for patients with immune checkpoint inhibitor (ICI)-refractory solid tumors will be presented in a special report at the 2026 American Association for Cancer Research (AACR) Annual Meeting.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
This groundbreaking study aims to evaluate the safety and preliminary efficacy of Pln-101095 in patients with advanced solid tumors, providing new potential directions for tumor immunotherapy.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Rosenblatt Securities raises Broadcom's target price to $600
格隆汇•2026/09/03 11:26
WTI Oil hits highs near $91 as risks of an all-out war in the Middle East grow
FXStreet•2026/09/03 11:24
Crypto prices
More
Bitcoin
BTC
$77,823.02
+1.89%
Ethereum
ETH
$2,400.64
+1.30%
Tether USDt
USDT
$0.9996
+0.01%
BNB
BNB
$705.6
+3.44%
XRP
XRP
$1.37
+3.80%
USDC
USDC
$0.9998
+0.01%
Solana
SOL
$100.6
+2.93%
TRON
TRX
$0.3281
+1.67%
Hyperliquid
HYPE
$81.86
+1.20%
Dogecoin
DOGE
$0.08306
+2.91%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now